Your browser doesn't support javascript.
loading
Discovery of novel co-degradation CK1α and CDK7/9 PROTACs with p53 activation for treating acute myeloid leukemia.
Wang, Kai; Jiang, Meixu; Liu, Huimin; Meng, Chen; Li, Mengyuan; Lu, Haibin.
Affiliation
  • Wang K; College of Pharmacy, Jilin University, Changchun 130021, China.
  • Jiang M; College of Pharmacy, Jilin University, Changchun 130021, China.
  • Liu H; College of Pharmacy, Jilin University, Changchun 130021, China.
  • Meng C; College of Pharmacy, Jilin University, Changchun 130021, China.
  • Li M; College of Pharmacy, Jilin University, Changchun 130021, China.
  • Lu H; College of Pharmacy, Jilin University, Changchun 130021, China. Electronic address: luhaibin@jlu.edu.cn.
Bioorg Chem ; 147: 107319, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38593529

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Screening Assays, Antitumor / Leukemia, Myeloid, Acute / Tumor Suppressor Protein p53 / Cyclin-Dependent Kinases / Cyclin-Dependent Kinase 9 / Casein Kinase Ialpha / Cell Proliferation / Antineoplastic Agents Limits: Humans Language: En Journal: Bioorg Chem Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Screening Assays, Antitumor / Leukemia, Myeloid, Acute / Tumor Suppressor Protein p53 / Cyclin-Dependent Kinases / Cyclin-Dependent Kinase 9 / Casein Kinase Ialpha / Cell Proliferation / Antineoplastic Agents Limits: Humans Language: En Journal: Bioorg Chem Year: 2024 Type: Article Affiliation country: China